Q: In a recent article that I read, the focus was on filtering “companies with expected ROE expansion driven by improving margins and total asset turnover, not financial engineering.”
Among those at the top of his list, the one that interested me was MDT.
- Do you agree that MDT should see favourable ROE going forward?
- Any concerns about valuation or competition?
- Would you agree that the requirement for MDT's devices would be more resilient during recessionary times compared to other types of surgeries?
Among those at the top of his list, the one that interested me was MDT.
- Do you agree that MDT should see favourable ROE going forward?
- Any concerns about valuation or competition?
- Would you agree that the requirement for MDT's devices would be more resilient during recessionary times compared to other types of surgeries?